Wagg, Adrian, Billy Franks, Barbara Ramos, and Todd Berner. “Persistence and Adherence With the New Beta-3 Receptor Agonist, Mirabegron, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada”. Canadian Urological Association Journal 9, no. 9-10 (October 13, 2015): 343-50. Accessed May 17, 2021. https://cuaj.ca/index.php/journal/article/view/3098.